ReviewPathogens (Basel, Switzerland)2022

Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens.

Marija Rozman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.